Par Drugs and Chemicals Limited (PAR.NS)
INR 103.99
(4.61%)
INR 103.99
(4.61%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 551.58 Million INR | 29.43% |
| 2022 | 149.74 Million INR | 15.42% |
| 2021 | 129.73 Million INR | -1.67% |
| 2020 | 131.93 Million INR | 97.3% |
| 2019 | 66.87 Million INR | 29.36% |
| 2018 | 51.69 Million INR | 6.68% |
| 2017 | 48.45 Million INR | -14.1% |
| 2016 | 56.41 Million INR | 24.31% |
| 2015 | 45.38 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 33.31 Million INR | -35.96% |
| 2024 Q2 | 105 Million INR | 215.2% |
| 2023 Q2 | 65.14 Million INR | 97.36% |
| 2023 Q1 | 33 Million INR | -27.21% |
| 2023 Q3 | 43.63 Million INR | -33.02% |
| 2023 Q4 | 52.02 Million INR | 19.21% |
| 2023 FY | 193.81 Million INR | 29.43% |
| 2022 Q2 | 50.07 Million INR | 60.91% |
| 2022 Q4 | 45.34 Million INR | 82.26% |
| 2022 FY | 149.74 Million INR | 15.42% |
| 2022 Q1 | 31.12 Million INR | -14.62% |
| 2022 Q3 | 24.88 Million INR | -50.31% |
| 2021 Q1 | 33.6 Million INR | -7.5% |
| 2021 FY | 129.73 Million INR | -1.67% |
| 2021 Q4 | 36.45 Million INR | 28.48% |
| 2021 Q3 | 28.37 Million INR | -12.36% |
| 2021 Q2 | 32.37 Million INR | -3.67% |
| 2020 Q4 | 36.33 Million INR | 9.71% |
| 2020 Q3 | 33.11 Million INR | 4.53% |
| 2020 FY | 131.93 Million INR | 97.3% |
| 2020 Q1 | 31.68 Million INR | 52.15% |
| 2020 Q2 | 31.68 Million INR | 0.0% |
| 2019 Q4 | 20.82 Million INR | 0.0% |
| 2019 FY | 66.87 Million INR | 29.36% |
| 2019 Q3 | 20.82 Million INR | 65.12% |
| 2019 Q2 | 12.61 Million INR | 0.0% |
| 2019 Q1 | 12.61 Million INR | 29.76% |
| 2018 Q4 | 9.71 Million INR | 0.0% |
| 2018 FY | 51.69 Million INR | 6.68% |
| 2018 Q1 | 15.91 Million INR | 0.0% |
| 2018 Q2 | 15.91 Million INR | 0.0% |
| 2018 Q3 | 9.71 Million INR | -38.92% |
| 2017 FY | 48.45 Million INR | -14.1% |
| 2016 FY | 56.41 Million INR | 24.31% |
| 2015 FY | 45.38 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 621.02 Million INR | 11.181% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -2570.357% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 92.366% |
| FDC Limited | 3.03 Billion INR | 81.818% |
| Gufic Biosciences Limited | 2.89 Billion INR | 80.939% |
| Hikal Limited | 1.49 Billion INR | 63.085% |
| Ind-Swift Laboratories Limited | 2 Billion INR | 72.545% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 88.839% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -165.123% |
| Medico Remedies Limited | 277.11 Million INR | -99.045% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 85.822% |
| RPG Life Sciences Limited | 2.29 Billion INR | 75.937% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Shilpa Medicare Limited | 3.76 Billion INR | 85.336% |
| Sigachi Industries Limited | 1.47 Billion INR | 62.576% |
| Themis Medicare Limited | 1.3 Billion INR | 57.671% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Venus Remedies Limited | 534.65 Million INR | -3.168% |
| Wanbury Limited | 1.7 Billion INR | 67.691% |
| ZIM Laboratories Limited | 1.09 Billion INR | 49.769% |
| Lupin Limited | 27.75 Billion INR | 98.013% |
| Innova Captab Limited | 2.53 Billion INR | 78.227% |
| Ind-Swift Limited | 1.22 Billion INR | 55.008% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 99.472% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 114.316% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 87.671% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -1908.846% |
| Morepen Laboratories Limited | 4.17 Billion INR | 86.785% |
| Laurus Labs Limited | 3.94 Billion INR | 86.031% |
| Aarti Drugs Limited | 7.14 Billion INR | 92.284% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 93.857% |
| Alembic Limited | 767.77 Million INR | 28.157% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 90.421% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 91.517% |
| Vaishali Pharma Limited | 6.29 Million INR | -8663.727% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 82.367% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -157.704% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 89.37% |
| Eris Lifesciences Limited | 5.18 Billion INR | 89.355% |
| Windlas Biotech Limited | 1.29 Billion INR | 57.534% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 99.471% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 71.065% |
| Orchid Pharma Limited | 2.36 Billion INR | 76.638% |
| Albert David Limited | 1.33 Billion INR | 58.666% |
| Hester Biosciences Limited | 364.77 Million INR | -51.216% |
| Sakar Healthcare Limited | 495.5 Million INR | -11.318% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 88.029% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 80.201% |
| Divi's Laboratories Limited | 18.31 Billion INR | 96.987% |
| Mankind Pharma Limited | 40.86 Billion INR | 98.65% |
| Neuland Laboratories Limited | 5.31 Billion INR | 89.628% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 92.686% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 98.785% |
| Wockhardt Limited | 140 Million INR | -293.992% |
| Bal Pharma Limited | 214.56 Million INR | -157.068% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 99.186% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | 55.192% |
| Alkem Laboratories Limited | 19.46 Billion INR | 97.166% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 97.197% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -132.091% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -19385.09% |
| Granules India Limited | 6.52 Billion INR | 91.551% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Ipca Laboratories Limited | 29.59 Billion INR | 98.136% |
| Brooks Laboratories Limited | -72.25 Million INR | 863.424% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -121.299% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 97.823% |
| NATCO Pharma Limited | 25.96 Billion INR | 97.875% |
| Suven Life Sciences Limited | -1.22 Billion INR | 144.997% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 89.445% |
| Indoco Remedies Limited | 1.52 Billion INR | 63.816% |
| Alpa Laboratories Limited | 61.51 Million INR | -796.674% |
| Lasa Supergenerics Limited | -458 Million INR | 220.433% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 113.404% |